发明申请
- 专利标题： 3, 10, and 12a Substituted tetracycline compounds
- 专利标题（中）： 3,10和12a取代的四环素化合物
-
申请号： US11069197申请日： 2005-02-28
-
公开(公告)号： US20050288262A1公开(公告)日： 2005-12-29
- 发明人: Upul Bandarage , Jackson Chen , Mohamed Ismail , Mark Nelson , Kwasi Ohemeng
- 申请人： Upul Bandarage , Jackson Chen , Mohamed Ismail , Mark Nelson , Kwasi Ohemeng
- 申请人地址： US MA Boston
- 专利权人： Paratek Pharmaceuticals, Inc.
- 当前专利权人： Paratek Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Boston
- 主分类号： A61K31/36
- IPC分类号： A61K31/36 ; A61K31/536 ; A61K31/65 ; A61P9/10 ; A61P11/00 ; A61P25/00 ; A61P25/16 ; A61P25/28 ; A61P27/02 ; A61P29/00 ; A61P35/00 ; A61P43/00 ; C07C237/26 ; C07D265/12 ; C07D317/54
摘要：
The present invention pertains to novel 3, 10, and/or 12a-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
公开/授权文献
- US07825105B2 3, 10, and 12a substituted tetracycline compounds 公开/授权日：2010-11-02
信息查询
